Taiwan FDA registration a574bd92571df595ab98b7aed05b3e6e
“Meril” Biomime Morph Sirolimus Eluting Coronary Stent System
TW: “渼瑞爾”拜歐邁茉福冠狀動脈塗藥支架系統
Taiwan·Risk Class 3·MD·Meril Life Sciences Pvt. Ltd.·Registered Jun 10, 2019 – Jun 10, 2024ExpiredRegistration details
- Analysis ID
- a574bd92571df595ab98b7aed05b3e6e
- License Form
- Ministry of Health Medical Device Import No. 031612
- Customs Code
- DHA05603161207
Company information
- Manufacturer
- Meril Life Sciences Pvt. Ltd.
- Manufacturer Country
- India
- Authorized Representative
- K&C MEDICAL CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E0001 Cardiovascular stents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 10, 2019
- Expiry Date
- Jun 10, 2024
About this record
Access comprehensive regulatory information for “Meril” Biomime Morph Sirolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a574bd92571df595ab98b7aed05b3e6e and manufactured by Meril Life Sciences Pvt. Ltd.. The authorized representative in Taiwan is K&C MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices